Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montreal, QC, Canada.
HLA Laboratory, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.
Int J Cancer. 2020 Oct 1;147(7):2000-2006. doi: 10.1002/ijc.32967. Epub 2020 Mar 19.
The THP-1 cell line is broadly used as a model for acute myeloid leukemia (AML) with MLL fusion and to study monocyte differentiation and function. We studied THP-1 cells obtained from two major biorepositories. The two cell lines were closely related with a percentage match of short tandem repeat (STR) profiles ranging from 93.75% to 100%, depending on the algorithm used. Nevertheless, we found that the two cell lines presented discordant HLA type, cytogenetic aberrations and AML-related gene expression (including critical targets of MLL fusion). These discrepancies resulted mainly from loss of heterozygosity (LOH) involving five chromosomal regions. In view of their aberrant expression of key "leukemia" genes (e.g., LIN28B, MEIS1 and SPARC), we argue that one of the THP-1 cell lines may not be a reliable model for studying leukemia. Their defective expression of HLA molecules and abnormal adhesion properties is also a caveat for studies of antigen presentation. In a more general perspective, our findings show that seemingly minor discrepancies in STR profiles among cell lines may be the sign of major genetic drift, of sufficient magnitude to affect the reliability of cell line-based research.
THP-1 细胞系被广泛用作具有 MLL 融合的急性髓系白血病 (AML)的模型,用于研究单核细胞分化和功能。我们研究了来自两个主要生物库的 THP-1 细胞。这两种细胞系密切相关,短串联重复序列 (STR) 谱的百分比匹配度为 93.75% 至 100%,具体取决于所使用的算法。尽管如此,我们发现这两种细胞系呈现出不一致的 HLA 类型、细胞遗传学异常和 AML 相关基因表达(包括 MLL 融合的关键靶标)。这些差异主要是由于涉及五个染色体区域的杂合性丢失 (LOH) 所致。鉴于它们关键“白血病”基因的异常表达(例如,LIN28B、MEIS1 和 SPARC),我们认为其中一种 THP-1 细胞系可能不是研究白血病的可靠模型。它们 HLA 分子的表达缺陷和异常的粘附特性也是抗原呈递研究的一个警告。从更广泛的角度来看,我们的发现表明,细胞系之间 STR 谱似乎较小的差异可能是主要遗传漂移的迹象,其幅度足以影响基于细胞系的研究的可靠性。